Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

Author:

Quintas Sonia,Zapata-Wainberg Gustavo,Arias-Rivas Susana,Ximénez-Carrillo Álvaro,Castillo Jose,Benavente Fernández Lorena,Masjuan Vallejo Jaime,Freijó Guerrero María del Mar,Egido José,García Pastor Andrés,Cardona Pere,Lago Aida,Castellanos Rodrigo Mar,Fuentes Blanca,Sobrado Mónica,Vivancos Jose

Abstract

<b><i>Background:</i></b> Intracerebral hemorrhage (ICH) is 7- to 10-fold higher in anticoagulated patients. Given the more extended use of oral anticoagulants, an increase in the prevalence of ICH associated with oral anticoagulation (ICH-OAC) could be expected. However, there is no previous study that assesses the time trends of ICH-OAC in Spain. <b><i>Methods:</i></b> We conducted a combined data analysis after creating a joint database of the 3 most important epidemiological studies on ICH-OAC of our country: the EPICES study (2008–2009), the TAC Registry (TR) study (2012–2013) and the TAC Registry 2 (TR2) study (2015). We finally included 65, 235, and 366 patients from the EPICES, TR, and TR2 studies, respectively. <b><i>Results:</i></b> We have observed a 3.73-fold increase in the crude annual incidence of ICH-OAC throughout the period of study, with proportion of ICH-OAC out of total ICH increasing from 8.4% in 2008 to 18.2% in 2015. Age, dyslipidemia, and prior antiplatelet treatment increased during the study, but we found no statistically significant differences in other risk factors for ICH-OAC. <b><i>Conclusions:</i></b> The incidence of ICH-OAC is increasing in our country. It might at least be partly explained by aging of the population, with mean age at presentation being higher in the last years.

Publisher

S. Karger AG

Subject

Neurology (clinical),Neurology

Reference24 articles.

1. Zapata-Wainberg G, Ximénez-Carrillo Rico Á, Benavente Fernández L, Masjuan Vallejo J, Gállego Culleré J, Freijó Guerrero MDM, et al. Epidemiology of intracranial haemorrhages associated with vitamin K antagonist oral anticoagulants in Spain: TAC registry. Interv Neurol. 2015;4(1–2):52–8.

2. Rodríguez Campello A, Roquer González J, Gomis Codina M, Munteis Olivas E, Ois Santiago ÁJ, Herraiz Rocamora J. Hemorragia cerebral en pacientes en tratamiento con anticoagulantes orales. Rev Neurol. 2005;40(1):19.

3. Navarro JL, Cesar JM, Fernández MA, Fontcuberta J, Reverter JC, Gol-Freixa J. Morbilidad y mortalidad en pacientes con tratamiento anticoagulante oral. Rev Esp Cardiol. 2007;60(12):1226–32.

4. Katz DF, Maddox TM, Turakhia M, Gehi A, O’Brien EC, Lubitz SA, et al. Contemporary trends in oral anticoagulant prescription in atrial fibrillation patients at low to moderate risk of stroke after guideline-recommended change in Use of the CHADS to the CHA2DS2 -VASc score for thromboemb. Circ Cardiovasc Qual Outcomes. 2017;10:e003476.

5. Gómez-Outes A, Lagunar-Ruíz J, Terleira-Fernández A-I, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2016;68:2508–21.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3